RxDoctor Payments DataLook up a doctor →

Corin Jaynes, PA

Physician Assistant · Charleston, SCNPI 1619217791

Payments from drug & device makers

$17,159in general payments, 2019–2025

Across 729 payments — averaging $23.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • Merck$1K
  • E.r. Squibb & Sons, L.L.C.$870
  • Johnson & Johnson$766
  • AstraZeneca$714
  • Lilly USA, LLC$649
  • plus $10K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis60$2,172
Merck50$1,159
E.r. Squibb & Sons, L.L.C.47$870
Johnson & Johnson(2 entities)35$766
AstraZeneca(2 entities)36$714
Lilly USA, LLC25$649
Pfizer31$610
Incyte Corporation26$557
Takeda Pharmaceuticals U.S.A., Inc.24$556
GSK26$488
Regeneron Healthcare Solutions, Inc.23$444
Amgen18$435
Bristol Myers Squibb20$432
Sanofi13$408
Eisai Inc.15$368
Gilead(2 entities)10$360
Seagen Inc.12$352
Daiichi Sankyo Inc.14$338
Genentech USA, Inc.16$322
AbbVie16$308
Jazz Pharmaceuticals Inc.14$288
Novocure Inc.5$251
Servier Pharmaceuticals LLC5$213
Bayer11$213
ADC Therapeutics America, Inc.11$210
Acrotech Biopharma Inc.8$195
Array Biopharma Inc11$191
Puma Biotechnology, Inc.9$179
Sobi, Inc8$178
Rigel Pharmaceuticals, Inc.7$154
Taiho Oncology, Inc.7$150
AVEO Pharmaceuticals, Inc.6$149
Ipsen Biopharmaceuticals, Inc6$137
Stemline Therapeutics Inc.5$133
Pharmaessentia USA Corporation6$132
G1 Therapeutics, Inc.6$124
Boehringer Ingelheim5$122
Karyopharm Therapeutics Inc.6$122
Beone Medicines USA, Inc.4$108
Sanofi-aventis U.S. LLC1$100
Genmab U.S., Inc.4$97
Beigene USA, Inc.4$82
GE HealthCare3$75
Morphosys, US Inc.4$68
Deciphera Pharmaceuticals Inc.2$65
Sumitomo Pharma America, Inc.2$63
Pharmacyclics LLC, An Abbvie Company4$60
Pharmacosmos Therapeutics Inc.3$60
Geron Corporation2$50
Myovant Sciences Inc.2$49
Adaptive Biotechnologies Corporation2$47
Mirati Therapeutics, Inc.2$42
Recordati_rare_diseases_inc.2$41
Legend Biotech USA Inc.1$41
Apellis Pharmaceuticals, Inc.2$40
Alnylam Pharmaceuticals Inc.2$38
Shield Therapeutics Inc2$38
Iovance Biotherapeutics, Inc.1$36
CSL Behring1$35
Acceleron Pharma, Inc.2$34

How this compares

$17,159 in reported general payments places this provider in the 95th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$75,059
Medicare patients
362
Services billed
1,281

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physician assistant in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →